Biontech investor calendar

Author: rudl

August undefined, 2024

WebJul 27, 2024 · AC Immune SA (NASDAQ: ACIU) has gained a multi-million investment from the principal backers of BioNTech SE (NASDAQ: BNTX) while acquiring a possible Parkinson's disease vaccine. WebNov 13, 2024 · All information in this press release is as of the date of the release, and BioNTech undertakes no duty to update this information unless required by law. CONTACTS. Media Relations Jasmina Alatovic +49 (0)6131 9084 1513 [email protected]. Investor Relations Sylke Maas, PhD. +49 (0)6131 9084 1074 …

AC Immune Secures Funding From BioNTech Investors, Buys

WebApr 10, 2024 · BIONTECH SE company earnings calendar and analyst expectations - Upcoming and past events Nasdaq: BNTX Nasdaq bird seed cylinders with hole

Financial Calendar BioNTech - investors.biontech.de

WebMar 23, 2024 · Every investor in BioNTech SE (NASDAQ:BNTX) should be aware of the most powerful shareholder groups. We can see that private equity firms own the lion's share in the company with 43% ownership. WebAug 9, 2024 · BioNTech stock analysts called for the company to earn $33.12 a share on $14.68 billion in sales for the year. BioNTech stock has a perfect Relative Strength … WebFeb 4, 2024 · BioNTech’s largest shareholders are biotech investors Thomas and Andreas Struengmann, who hold about half of the company’s shares between them. ($1 = 0.8341 … bird seed cube

BioNTech and Pfizer announce completion of dosing for first …

Early backers of vaccine maker BioNTech in $719 million payday

WebOct 9, 2024 · Funding. BioNTech has raised a total of $1.7B in funding over 9 rounds. Their latest funding was raised on Apr 14, 2024 from a Post-IPO Equity round. BioNTech is … WebFilings Registration Statements Filing year - Any - 2024 2024 2024 2024 Items per page 10 25 50 sort by Filing … Description Description sort by Form Form View 22 December 2024 Report of foreign issuer rules 13a-16 and 15d-16 of the … 0001776985-22-000087.xls View HTML 9 December 2024 Report of foreign issuer rules 13a-16 and 15d-16 of the … dan and catherine peekWebMar 18, 2024 · For their portion of the partnership, Fosun paid $50 million to purchase 1.58 million BioNTech shares, and will provide $85 million for development and commercialization fees. bird seed crafts

"WebApr 10, 2024 · In the last 3 months, 12 analysts have offered 12-month price targets for BioNTech. The company has an average price target of $169.33 with a high of $216.00 … " - Biontech investor calendar

Biontech investor calendar

BioNTech Investor Fortunes Rise and Fall on Headlines, Pacts …

WebApr 7, 2024 · Economic Calendar; Earnings; IPO Calendar; Dividend Calendar; ... The projected annual revenue for BioNTech SE is $9,869MM, a decrease of 42.99%. ... data … WebInvestors. Investors Overview Information for stockholders Why Invest Why to join us in our mission Events & Presentations Calendar of upcoming events Financial Reports Quarterly reports and more Investor News ... Emergency uses of Pfizer-BioNTech COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine, Bivalent have not been approved …

Did you know?

WebAug 8, 2024 · On today's stock market, BNTX stock crumbled 7.5% and closed at 169.30. BioNTech reiterated its guidance for 13 billion to 17 billion euros in full-year Covid vaccine sales. That translates to ... WebMar 27, 2024 · BioNTech earned 9.26 euros a share on 4.28 billion euros in sales. That comes out to about $9.97 and $4.61 billion, respectively. Both metrics topped BNTX …

WebApr 11, 2024 · 13 analysts have issued twelve-month price targets for BioNTech's shares. Their BNTX share price forecasts range from $130.00 to $260.00. On average, they anticipate the company's share price to reach $178.50 in the next twelve months. This suggests a possible upside of 38.5% from the stock's current price. WebJan 29, 2024 · Let's examine three things that smart investors are likely to understand about this stock. Image source: Getty Images. 1. Comirnaty will need to keep evolving. BioNTech's only product on the ...

WebJun 5, 2024 · Calendars. Trending Tickers. Stocks: Most Actives. Stocks: Gainers. Stocks: Losers. Top ETFs. ... E-mail: [email protected]. Media Relations Jasmina Alatovic VP Corporate Communications Tel ... WebApr 6, 2024 · Earnings Summary. For their last quarter, BioNTech (BNTX) reported earnings of $9.46 per share, beating the Zacks Consensus Estimate of $8.04 per share. …

WebApr 29, 2024 · BioNTech Media Relations Jasmina Alatovic Senior Manager Global External Communications Tel: +49 (0)6131 9084 7640 or +49 (0)151 1978 1385 E-mail: [email protected] BioNTech Investor Relations

WebNov 7, 2024 · BioNTech invites investors and the general public to join a conference call and webcast with investment analysts on November 7, 2024 at 8.00 a.m. EDT (2.00 p.m. CEST) to report its financial results and provide a corporate update for the third quarter of 2024. To access the live conference call via telephone, please register via this link. bird seed cromerWebFinancial Calendar BioNTech - investors.biontech.de bird seed cupsWebJan 11, 2024 · BioNTech SE said its revenue from the Covid-19 shot it sells together with Pfizer Inc. may be lower this year than last, predicting sales between 13 billion euros and … birdseed craftWebMay 9, 2024 · BioNTech's first-quarter sales and earnings more than tripled thanks to demand for the COVID-19 vaccine it developed with Pfizer , but the German biotech firm … dan and charlieWebView the latest BioNTech SE ADR (BNTX) stock price, news, historical charts, analyst ratings and financial information from WSJ. bird seed cylindersWebNov 30, 2024 · BioNTech: Media Relations Jasmina Alatovic +49 6131 9084 1513 [email protected]. Investor Relations Sylke Maas, Ph.D. +49 6131 9084 1074 [email protected]. Ryvu Therapeutics: Investors Contact: John Fraunces LifeSci Advisors +1 917-355-2395 [email protected]. Media Contact: Natalia … bird seed delivery serviceWebMar 20, 2024 · BioNTech Investor Relations Michael Horowicz +1 617 955 7420 [email protected]. Media Relations Jasmina Alatovic +49 (0)6131 9084 1513 [email protected]. OncoC4 Investor Relations Martin Devenport birdseed cupcakes